As of Jun 27
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Boston Therapeutics Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The median estimate represents a +4,366.50% increase from the last price of 0.04.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.